Navigation Links
Human Genome Sciences Presents New Data Showing Anti-Tumor Activity And Safety Of Trail Receptor Antibodies In Combination With Chemotherapy
Date:10/24/2007

- Results of first reported clinical trial of any antibody to TRAIL receptor 2 in combination with chemotherapy, presented at AACR-NCI-EORTC

International Conference - - Preclinical study demonstrating synergy of TRAIL receptor antibodies with

chemotherapy highlighted by meeting organizers in press activities -

ROCKVILLE, Md., Oct. 24 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that HGS-ETR2 (lexatumumab) was safe and well tolerated in combination with four different standard chemotherapy regimens in a Phase 1b clinical trial in patients with a wide range of cancer types. Objective responses were reported for two patients, and stable disease was observed in 22 patients. The trial was the first reported human study of an antibody to TRAIL receptor 2 in combination with chemotherapy. The results were presented today at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in San Francisco.

(Logo: http://www.newscom.com/cgi-bin/prnh/20010612/HGSLOGO )

The company also presented preclinical data demonstrating that HGS-ETR1 (mapatumumab) and HGS-ETR2 in combination with chemotherapy synergistically enhanced anti-tumor activity in cholangiocarcinoma (cancer of the bile ducts). In a xenograft model of cholangiocarcinoma, the results demonstrated that HGS- ETR1 and either co-treatment or pre-treatment with cisplatin and gemcitabine were more effective than chemotherapy or HGS-ETR1 alone.

"The clinical and preclinical results presented today add to a growing body of data showing that our agonistic antibodies to TR
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Testing for Human Papillomavirus
2. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
3. Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog Liraglutide, Brings Patients to A1c Target
4. Apollos human proteins boost stem cell research
5. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
6. Modigene Announces Successful Completion of Pharmacokinetic & Pharmacodynamic Pre-Clinical Experiments for Proprietary Long-Acting Human Growth Hormone, Long-acting Interferon Beta and Long-acting Erythropoietin
7. Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -
8. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
9. Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B Showed Significant Reductions in Disease Activity in Patients with Active Systemic Lupus Erythematosus
10. NCI Researchers Discover Genes That Are Turned on at High Levels in Tumor-associated Blood Vessels of Mice and Humans
11. Research Indicates Gerons Human Embryonic Stem Cell-Based Therapeutic for Spinal Cord Injury Evades Direct Attack by the Human Immune System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Dec. 15 PDL BioPharma, Inc. (PDL) (Nasdaq: ... the December 15, 2009 special dividend payment of $1.67 ... as of December 1, 2009. With this payment, ... 2009 total $2.67 per share. In January 2010, ... tax characteristics of the Company,s 2009 cash distributions and ...
(Date:12/15/2009)... -- West Pharmaceutical Services, Inc. (NYSE: WST ... approved payment of the first-quarter 2010 cash dividend of ... February 3, 2010 to shareholders of record on January ... West is a global manufacturer of components and systems ... vials, and closures and disposable components used in syringe, ...
(Date:12/15/2009)... Dec. 15 OrthoWorx, the newly formed industry, ... orthopedics device sector in Kosciusko County, is working to ... cities like Chicago and Cleveland via high-speed rail. ,, ... Indiana: The Orthopedics Capital of the World -- ... community growth, BioCrossroads, the statewide initiative to ...
Breaking Medicine Technology:PDL BioPharma Completes December 15 Special Dividend Payment 2OrthoWorx Urges Warsaw's Inclusion on High-Speed Rail Corridor Connecting Chicago and Cleveland 2OrthoWorx Urges Warsaw's Inclusion on High-Speed Rail Corridor Connecting Chicago and Cleveland 3Dust control research leads to a NIOSH grant to facilitate adoption of hazard controls 60982 1Dust control research leads to a NIOSH grant to facilitate adoption of hazard controls 60982 2Dust control research leads to a NIOSH grant to facilitate adoption of hazard controls 60982 3Book by UC Riverside biologist explains Darwins Origin of Species 60979 1Book by UC Riverside biologist explains Darwins Origin of Species 60979 2Antarctica glacier retreat creates new carbon dioxide store 10666 1Antarctica glacier retreat creates new carbon dioxide store 10666 2
... announced clinical,trial data for Seroquel sustained ... the European Congress of Psychiatry,(ECP) in ... SEROQUEL®,sustained release formulation (quetiapine fumarate sustained,release), ... with schizophrenia (measured by PANSS) and ...
... 2007 - Calando,Pharmaceuticals, a leading siRNA therapeutics ... Corporation,(NASDAQ: ARWR) announced the publication in the ... the scientific journal of the,NAS, of the ... systemic,dosing with Calando's lead siRNA therapeutic candidate ...
Other Medicine Technology:Seroquel Sustained Release Schizophrenia Data Presented at ECP,Congress in Madrid 2Seroquel Sustained Release Schizophrenia Data Presented at ECP,Congress in Madrid 3Seroquel Sustained Release Schizophrenia Data Presented at ECP,Congress in Madrid 4Calando Pharmaceuticals Publishes the First Non-Human Primate Study,on Targeted, Systemic Delivery of siRNA in National Academy of,Sciences Journal 2Calando Pharmaceuticals Publishes the First Non-Human Primate Study,on Targeted, Systemic Delivery of siRNA in National Academy of,Sciences Journal 3Calando Pharmaceuticals Publishes the First Non-Human Primate Study,on Targeted, Systemic Delivery of siRNA in National Academy of,Sciences Journal 4Calando Pharmaceuticals Publishes the First Non-Human Primate Study,on Targeted, Systemic Delivery of siRNA in National Academy of,Sciences Journal 5
(Date:12/16/2009)... , , TUESDAY, Dec. 15 (HealthDay News) -- If that ... on your life that you just can,t wait to have ... you might want to wait at least six months before ... be even better. , The study found that when ... chances of the baby dying, being born prematurely, having birth ...
(Date:12/16/2009)... Inc. ("TSO3") (TSX: TOS) and 3M (MMM) today ... 3M to be the exclusive supplier and distributor ... TSO3, an innovator in low temperature sterilization technology ... use of ozone, will include new cycles to ... channel. This agreement, combined with recent improvements to ...
(Date:12/16/2009)... development of products that help survivors of stroke and other ... publication of an interview with the inventors of their brand ... Therapy and Rehab Medicine, vol. 20, issue 20, page 26, ... ... (PRWEB) December 16, 2009 -- In the publication, ...
(Date:12/16/2009)... another product or thing for your loved ones this holiday season, ... services like housekeeping, errand running, child care, and pet care through ... ... 2009 -- Residents of the Denver and Boulder metro areas have ... friends and loved ones by using Delegate Source,s " Give a ...
(Date:12/15/2009)... a Life Sciences company engaged in the research, development and commercialization of technologies that target ... the Company had proposed at the Annual General Meeting of Shareholders held on December 14, ... Votes ... Non-, Matter ... For Against ...
Breaking Medicine News(10 mins):Health News:For Babies' Sake, Pregnancy Spacing Matters 2Health News:For Babies' Sake, Pregnancy Spacing Matters 3Health News:TSO3 and 3M agree to global channel partnership - 3M to begin rollout in sequential markets as regulatory clearances are received 2Health News:TSO3 and 3M agree to global channel partnership - 3M to begin rollout in sequential markets as regulatory clearances are received 3Health News:TSO3 and 3M agree to global channel partnership - 3M to begin rollout in sequential markets as regulatory clearances are received 4Health News:New Tailwind Device Improves Arm Function in Stroke Survivors with Paralysis 2Health News:Give the Gift of Service This Holiday Season with Delegate Source 2Health News:Give the Gift of Service This Holiday Season with Delegate Source 3Health News:Senetek PLC Announces 2009 Annual General Meeting Voting Results 2Health News:Senetek PLC Announces 2009 Annual General Meeting Voting Results 3
... Against More Diseases than Ever ... ... immunization,recommendations for childhood influenza and adolescent meningococcal,vaccinations are included in the ... for Disease Control and,Prevention (CDC), the American Academy of Pediatrics (AAP), ...
... $450K to Prop ... 93, ... be compelled to buy health insurance under the,Massachusetts mandatory purchase law, according to ... plan pending in,California., As reported in the Boston Globe, Jonathan Gruber, a ...
... 11 International Dairy,Foods Association (IDFA) President and CEO ... Food Safety Authority (EFSA),released its draft report on animal ... United States was a full,year ago with respect to ... animal cloning. Today,s draft scientific report is,simply the first ...
... Comprehensive health care reform is too important, the stakes for, ... ... changes., SACRAMENTO, Calif., Jan. 11 As ... reform,proposal hammered out by Governor Arnold Schwarzenegger and Assembly,Speaker Fabian Nunez, the ...
... officials announced,today that a new generic prescription drug program ... and drugstores., The program offers a 30-day supply ... prescription. The medicines on the list include antibiotics and ... and digestive issues., There are no forms to ...
... how the two sexes evolved , FRIDAY, Jan. 11 (HealthDay News) ... contain clues to gender development in humans. , Duke University researchers ... Nature . , In research with Phycomyces blakesleeanus , ... mating. They named these versions sexM (sex minus) and sexP (sex ...
Other Medicine News:Health News:Health Groups Release 2008 Immunization Schedules 2Health News:MA Proponent of Health Insurance Mandate Says 'Mean' Penalties Needed to Force People to Buy Insurance 2Health News:IDFA: Dairy Processors Urge Further Review of Cloning 2Health News:Insurance Agents Call for State Senate to Improve California's Health Care Reform Compromise 2Health News:Hy-Vee Unveils New Generic Drug Program 2Health News:Fungus Sheds Light on Development of Human Genders 2
... The autoLog™ Autotransfusion System processes blood ... produce washed red blood cells for ... later time. This is achieved with ... An innovative bowl design, coupled with ...
The Wixson Hip Positioner is used for stable positioning of a patient during total hip and revision surgery. It is designed to be placed on top of the operating table....
Stryker Instruments InterPulse System advances the ease and performance of battery powered irrigation for Orthopaedics, Trauma, and Wound Care....
... VersaNail System is a complete system of ... use with TTC fusion surgery. The system ... and integrates clinical research and engineering with ... every patient is different, and because the ...
Medicine Products: